Status:
COMPLETED
Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris
Lead Sponsor:
LEO Pharma
Conditions:
Psoriasis Vulgaris
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Patients with psoriasis vulgaris of the trunk and/or limbs are randomised to treatment with: 1. 4 weeks of ointment containing calcipotriol and betamethasone dipropionate followed by 8 weeks of calci...
Detailed Description
A phase IV study of different treatment regimens of calcipotriol 50 mcg/g cream and combination (calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate)) ointment following treatment with ...
Eligibility Criteria
Inclusion
- Patients with psoriasis vulgaris of trunk and/or limbs
Exclusion
- \-
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
1032 Patients enrolled
Trial Details
Trial ID
NCT00216892
Start Date
April 1 2005
End Date
December 1 2005
Last Update
February 24 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis
Ghent, Belgium, 9000
2
Dermatrials Research Dermatology Centre
Hamilton, Ontario, Canada, L8N 1V6
3
Hôpital Nord, Service de Dermatologie
Saint-Etienne, France, 42055
4
Klinikum der Goethe-Universität, Zentrum für Dermatologie und Venerologie
Frankfurt, Germany, 60590